Inhibition of the NF-κB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-κB essential modulator NEMO

Cell Death and Differentiation

Volumn 15, Issue 1, 2008, Pages 152-160

  Frelin, C ^a,b   Imbert, V ^a,b   Bottero, V ^c   Gonthier, N ^a,b   Samraj, A K ^d   Schulze Osthoff, K ^d   Auberger, P ^a,b   Courtois, G ^a   Peyron, J F ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d Institute of Laser Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CASPASE; CASPASE INHIBITOR; I KAPPA B KINASE; I KAPPA B KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN ESSENTIAL MODULATOR; SCAFFOLD PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHUK PROTEIN, HUMAN; IKBKG PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MUTANT; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENSITIVITY ANALYSIS; CELL SURVIVAL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASES; CELL SURVIVAL; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37349102503     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402240     Document Type: Article

References (43)

1. Karin M, Ban-Neriah Y. Phosphorylation meet ubiquitination: The control of NF-κB activity. Annu Rev Immmunol 2000; 18: 621-663.
2. Pahl H. Activators and target genes of Rel/NF-κB transcripion factors. Oncogene 1999; 18: 6853-6866.
3. Scheiderek C. IκB kinase complexes: Gateways to NF-κB activation and transcription. Oncogene 2006; 25: 6685-6705.
4. Pomerantz J, Baltimore D. Two pathways to NF-κB. Mol Cell 2002; 10: 693-701.
5. Yamaoka CS, Ceurtois G, Bessia C, Whiteside S, Weil R, Agou F et al. Complementation cloning of NEMO a component of the IκB kinase complex essential for NF-κB activation. Cell 1998; 93: 1231-1240.
6. Beg AA, Sha WC, Brenson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167-170.
7. Li Q, Van Antwerp D, Mercurio F, Lee K, Verma I. Severe liver degeneration in mice lacking the IκB Kinase 2 gene. Science 1999; 284: 321-325.
8. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, Potter J et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IK Kgamma-deficient mice. Genes Dev 2000; 14: 854-862.
9. Cheng Q, Lee H, Li Y, Parks T, Chang G. Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which eon be overcome by NF-κB inhibition. Onoogene 2000; 19: 4936-4940.
10. Karin M, Lin A. NF-κB at the crossrpads of life and death. Nat Immunol 2002; 3: 221-227.
11. Van Antwerp DJ, Martin SJ, Verma IM, Green DR. Inhibition of TNIF-induced apoptosis by NF-kappa B. Trends Cell Biol 1998; 8 107-111.
12. Frelin O, Imbert V, Griessinger M, Loubat A, Dreano M, Peyron J-F. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic T cells. Oncogene 2003; 22: 8187-8194.
13. Keane M, Rubinstein Y, Cuello M, Ettenberg S, Banerjee P, Nau M et al. Inhiebition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lienes. Breast Cancer Res Treat 2000; 64:eEe 211-219.
14. Wang CY, Mayo MW, Baldwin Jr AS. TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 1996; 274: 784-787.
15. Bottero V, Busuttil V, Loubat A, Magné N, Fischel J, Milano G et al. Activation of Nuclear Factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: A brake to apoptosis in HeLa human carcinoma cells. Cancer Res 2001; 61: 7785-7791.
16. Frelin C, Imbed V, Griessinger M, Peyron A, Rochet N, Philip P et al. Targeting NF-κB activation via pharmacological inhibition of IKK2, induced apoptosis of human acute myeloid leukemia cells. Blood 2005; 105: 804-811.
17. Busuttil V, Bottero V, Frelin C, Imbert V, Ricci J, Auberger P et al. Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. Oncogene 2002; 21: 3213-3224.
18. Karin M, Cao Y, Greten F, Li Z. NF-κB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301-310.
19. Fischer U, Jänicke R, Schulze-Osthoff K. Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 2003; 10: 76-100.
20. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003; 22: 8543-8567.
21. Luciano F, Ricci J, Auberger P. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: A new mechanism for Src kinase regulation. Oncogene 2001; 20: 4935-4941.
22. Bertolotto C, Ricci J, Luciano F, Mari B, Chambard J, Auberger P. Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-fos promoter transcriptional activity. J Biol Chem 2000; 275: 37246-37250.
23. Levkau B, Scatena M, Glachelh C, Ross R, raines E. Apoptosis overrides survival signals through-a caspase-mediated dominant negative NF-κB loop. Nat Cell Biol 1999; 1: 227-233.
24. Desagher S, Martinou M. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369-377.
25. Silverman N, Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001; 15: 2321-2342.
26. Samraj A, Keil E, Ueffing N, Schuize-Osthoff K, Schmitz I. Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis. J Biol Chem 2006; 40: 29652-29659.
27. Eamshaw W, Martina L, Kaufmann S. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
28. Rothwarf D, Zandi E, Natoli G, Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 1998; 395 297-300.
29. Agou F, Ye F, Goffinont S, Courtois G, Yamaoka S, Israël A et al. NEMO trimerizes through its coiled-coil C-terminal domain. J Biol Chem 2002; 277: 17464-17475.
30. Ye J, Yie X, Tarassishin L, Horwitz M. Regulation of the NF-κB activation pathway by isolated domains of FIP3/IKKγ, a component of the IκB-α kinase complex. J Biol Chem 2000; 275: 9882-9889.
31. Huang T, Feinberg S, Suryanarayanan S, Miyamoto S. The zinc finger of NEMO is selectively required for NF-κB activation by UV radiation and lopoisomerass, poisons. Mol Cell Biol 2002, 22: 5813-5825.
32. Makris C, Roberts J, Karin M. The carboxy-terminal region Of IκB kinase γ, (IKKγ) is, required for full IKK activation. Mol Cell Biol 2002; 22: 6573-6581.
33. Kucharczack J, Simmons M, Fan Y, Gélinas C. To be, or not to be: NF-κB is the answer-role of Rel/NF-κB in the regulation of apoptosis. Oncogene 2003; 22: 8961-8982.
34. Courtois G, Smahl A, Israël A. NEMO/IKKγ: Linking NF-κB to human disease. Trends Mol Med 2001; 7: 427-430.
35. Arch RH, Gedrich RW, Thompson CR. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev 1998; 12: 2821-2830.
36. Deveraux Q, Reed J. IAP familly proteins-suppressors of apoptosis. Genes Dev 1999; 13: 239-252.
37. Tang G, Yang J, Minemoto Y, Lin A. Blocking caspase-3 mediated, proteolysis of IKKβ suppresses TNFα-induced apoptosis. Mol Cell 2001; 8: 1005-1016.
38. Reuther J, Baldwin Jr A. Apoptosis promotes a caspase-induced amino-terminal truncation of IκBα as a stable inhibitor of NF-κB. J Biol Chem 1999; 274: 20664 -20670.
39. Los M, Stroh C, Jänicke R, Engels I, Schulze-Osthoff Caspases: More than just killers? Trends Immunol 2001; 22: 31-34.
40. Zermati Y, Garrido C, Arosellem S, Fishelson S, Bouscary D, Valensi F et al. Caspase activation-is required for terminal erythroid differentiation. J Exp Med 2001; 193: 247-254.
41. Juo P, Kuo C, Yuan J, Blenis J. Essential requirement for caspase-8/ FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998; 8: 1001-1008.
42. Harhaj E, Good L, Xiao G, Uhlik M, Cvijic M, Rivera-Walsh I et al. Somatic-mutagenesis studies of NF-κB signaling in human T cells: evidence for an essential role of IKKγ in NF-κB activation by T-cell costimulatory signals and HTLV-I tax protein. Oncogene 2000; 19 1448-1456.
43. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner BM, Mueller-Dieckmann C et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996; 86: 787-798.